ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 34 filers reported holding ETON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,845 | -81.5% | 922 | -82.9% | 0.00% | – |
| Q1 2023 | $20,740 | +86.7% | 5,387 | +36.8% | 0.00% | – |
| Q4 2022 | $11,108 | -20.7% | 3,939 | -38.8% | 0.00% | – |
| Q3 2022 | $14,000 | +40.0% | 6,433 | +70.7% | 0.00% | – |
| Q2 2022 | $10,000 | -50.0% | 3,768 | -17.3% | 0.00% | – |
| Q1 2022 | $20,000 | +17.6% | 4,555 | +11.7% | 0.00% | – |
| Q4 2021 | $17,000 | -48.5% | 4,079 | -23.9% | 0.00% | – |
| Q2 2021 | $33,000 | 0.0% | 5,363 | +19.4% | 0.00% | – |
| Q1 2021 | $33,000 | -26.7% | 4,492 | -19.0% | 0.00% | – |
| Q4 2020 | $45,000 | +40.6% | 5,545 | +38.5% | 0.00% | – |
| Q3 2020 | $32,000 | +23.1% | 4,004 | -16.3% | 0.00% | – |
| Q2 2020 | $26,000 | -7.1% | 4,783 | -28.9% | 0.00% | – |
| Q1 2020 | $28,000 | +55.6% | 6,731 | +164.0% | 0.00% | – |
| Q4 2019 | $18,000 | +100.0% | 2,550 | +114.5% | 0.00% | – |
| Q2 2019 | $9,000 | -86.8% | 1,189 | -86.1% | 0.00% | – |
| Q1 2019 | $68,000 | – | 8,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,040,000 | $32,845,000 | 4.29% |
| AWM Investment Company, Inc. | 971,681 | $7,900,000 | 1.00% |
| Diametric Capital, LP | 51,633 | $420,000 | 0.33% |
| Mesirow Financial Investment Management, Inc. | 1,046 | $8,504,000 | 0.03% |
| Hood River Capital Management LLC | 76,397 | $621,000 | 0.02% |
| Westside Investment Management, Inc. | 83,900 | $4,743,000 | 0.01% |
| MML INVESTORS SERVICES, LLC | 129,250 | $1,051,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 31,961 | $260,000 | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 126,490 | $1,028,000 | 0.00% |
| SEI INVESTMENTS CO | 76,397 | $621,000 | 0.00% |